Galili antigen pentaose linked to biotin (Linker-BT A)
|
|
|
Galili antigen pentaose grafted on CRM197
|
|
|
Galili antigen pentaose grafted on OVA
|
|
|
Galili antigen pentaose with terminal alkyne (Linker-CΞCH C)
|
|
|
Xeno antigen type 1 grafted on BSA
|
|
|
Xeno antigen type 2 / Galili antigen triose grafted on BSA
|
|
|
Galili antigen heptaose linked to biotin (Linker-BT C)
|
|
|
Galili antigen heptaose linked to desthiobiotin (Linker-DBT-A)
|
|
|
Galili antigen heptaose with customizable dual functionalization
|
|
|
Galili antigen nonaose (>85% NMR)
|
|
|
Galili antigen pentaose grafted on KLH
|
|
|
Galili antigen pentaose with free terminal amine (Linker-NH2 B)
|
|
|
Galili antigen pentaose with stearic chain (Linker-STEA A)
|
|
|
Isoglobopentaose (iGb5) grafted on OVA
|
|
|
Xeno antigen type 1 grafted on HSA
|
|
|
Galili antigen heptaose grafted on BSA
|
|
|
Galili antigen heptaose linked to biotin and stearic chain (Linker-BT-STEA A)
|
|
|
Galili antigen heptaose with free terminal amine (Linker-NH2 C)
|
|
|
Galili antigen heptaose with terminal alkyne (Linker-CΞCH A)
|
|
|
Galili antigen pentaose grafted on gel for affinity chromatography (Linker-GEL A)
|
|
|
Galili antigen pentaose with terminal azide (Linker-N3 A)
|
|
|
Isoglobopentaose (iGb5) grafted on CRM197
|
|
|
Isoglobopentaose (iGb5) with free terminal amine (Linker-NH2 B)
|
|
|
Xeno antigen type 2 / Galili antigen triose grafted on OVA
|
|
|
Xeno lewis x / α-Gal-Lewis x grafted on KLH
|
|
|
Galili antigen heptaose grafted on HSA
|
|
|
Galili antigen heptaose with terminal azide (Linker-N3 B)
|
|
|
Galili antigen nonaose linked to biotin (Linker-BT C)
|
|
|
Galili antigen nonaose linked to desthiobiotin (Linker-DBT-A)
|
|
|
Galili antigen pentaose linked to biotin (Linker-BT B)
|
|
|
Galili antigen pentaose with DBCO (Linker-DBCO A)
|
|
|
Galili antigen pentaose with customizable dual functionalization
|
|
|
Isoglobopentaose (iGb5) (>90% NMR)
|
|
|
Xeno antigen type 1 grafted on CRM197
|
|
|
Xeno antigen type 2 / Galili antigen triose grafted on CRM197
|
|
|
Galili antigen heptaose linked to biotin and fluorescein (Linker-BT-FLUO A)
|
|
|
Galili antigen heptaose linked to fluorescein (Linker-FLUO A)
|
|
|
Galili antigen heptaose with stearic chain (Linker-STEA A)
|
|
|
Galili antigen nonaose grafted on BSA
|
|
|
Galili antigen pentaose (>90% NMR)
|
|
|
Galili antigen pentaose linked to biotin and fluorescein (Linker-BT-FLUO A)
|
|
|
Galili antigen pentaose with free terminal amine (Linker-NH2 C)
|
|
|
Galili antigen pentaose with terminal alkyne (Linker-CΞCH A)
|
|
|
Isoglobopentaose (iGb5) with terminal alkyne (Linker-CΞCH A)
|
|
|
Xeno antigen type 1 grafted on KLH
|
|
|
Galili antigen heptaose linked to biotin (Linker-BT A)
|
|
|
Galili antigen heptaose grafted on CRM197
|
|
|
Galili antigen heptaose with free terminal amine (Linker-NH2 D)
|
|
|
Galili antigen heptaose with terminal alkyne (Linker-CΞCH B)
|
|
|
Galili antigen pentaose grafted on gel for affinity chromatography (Linker-GEL B)
|
|
|
Galili antigen pentaose with terminal azide (Linker-N3 B)
|
|
|
Isoglobopentaose (iGb5) linked to desthiobiotin (Linker-DBT-A)
|
|
|
Isoglobopentaose (iGb5) with free terminal amine (Linker-NH2 C)
|
|
|
Xeno lewis x / α-Gal-Lewis x (>90% NMR)
|
|
|
Xeno lewis x / α-Gal-Lewis x grafted on OVA
|
|
|
Galili antigen heptaose grafted on KLH
|
|
|
Galili antigen heptaose with free terminal amine (Linker-NH2 A) Hydrochloride form
|
|
|
Galili antigen nonaose linked to biotin and fluorescein (Linker-BT-FLUO A)
|
|
|
Galili antigen nonaose linked to fluorescein (Linker-FLUO A)
|
|
|
Galili antigen pentaose linked to biotin (Linker-BT C)
|
|
|
Galili antigen pentaose linked to desthiobiotin (Linker-DBT-A)
|
|
|
Galili antigen pentaose with cyclic di-thiol (Linker-LIPO A)
|
|
|
Isoglobopentaose (iGb5) grafted on BSA
|
|
|
Isoglobopentaose (iGb5) grafted on HSA
|
|
|
Xeno antigen type 2 / Galili antigen triose grafted on HSA
|
|
|
Xeno lewis x / α-Gal-Lewis x grafted on CRM197
|
|
|
Galili antigen heptaose grafted on gel for affinity chromatography (Linker-GEL A)
|
|
|
Galili antigen heptaose linked to maleimide (Linker-MAL A)
|
|
|
Galili antigen nonaose linked to biotin (Linker-BT A)
|
|
|
Galili antigen nonaose grafted on CRM197
|
|
|
Galili antigen pentaose grafted on BSA
|
|
|
Galili antigen pentaose linked to biotin and stearic chain (Linker-BT-STEA A)
|
|
|
Galili antigen pentaose with free terminal amine (Linker-NH2 D)
|
|
|
Galili antigen pentaose with terminal alkyne (Linker-CΞCH B)
|
|
|
Xeno antigen type 1 (>85% NMR)
|
|
|
Xeno antigen type 1 grafted on OVA
|
|
|
Galili antigen heptaose linked to biotin (Linker-BT B)
|
|
|
Galili antigen heptaose with DBCO (Linker-DBCO A)
|
|
|
Galili antigen heptaose grafted on OVA
|
|
|
Galili antigen heptaose with terminal alkyne (Linker-CΞCH C)
|
|
|
Galili antigen pentaose grafted on HSA
|
|
|
Galili antigen pentaose with free terminal amine (Linker-NH2 A) Hydrochloride form
|
|
|
Isoglobopentaose (iGb5) grafted on gel for affinity chromatography (Linker-GEL A)
|
|
|
Isoglobopentaose (iGb5) with free terminal amine (Linker-NH2 D)
|
|
|
Xeno lewis x / α-Gal-Lewis x grafted on BSA
|
|
|
Galili antigen heptaose (>90% NMR)
|
|
|
Galili antigen heptaose with cyclic di-thiol (Linker-LIPO A)
|
|
|
Galili antigen heptaose with free terminal amine (Linker-NH2 B)
|
|
|
Galili antigen nonaose linked to biotin and stearic chain (Linker-BT-STEA A)
|
|
|
Galili antigen nonaose grafted on gel for affinity chromatography (Linker-GEL A)
|
|
|
Galili antigen pentaose linked to fluorescein (Linker-FLUO A)
|
|
|
Galili antigen pentaose linked to maleimide (Linker-MAL A)
|
|
|
Isoglobopentaose (iGb5) linked to biotin (Linker-BT A)
|
|
|
Isoglobopentaose (iGb5) grafted on KLH
|
|
|
Xeno antigen type 2 / Galili antigen triose grafted on KLH
|
|
|
Xeno lewis x / α-Gal-Lewis x grafted on HSA
|
|
|
Galili antigen heptaose grafted on gel for affinity chromatography (Linker-GEL B)
|
|
|
Galili antigen heptaose with terminal azide (Linker-N3 A)
|
|
|
Galili antigen nonaose linked to biotin (Linker-BT B)
|
|
|
Galili antigen nonaose with DBCO (Linker-DBCO A)
|
|
|